 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bethfj@merge.com
|
|
Kenneth D. Rardin
President and CEO
Merge Healthcare
414.977.4000
ir@merge.com
|
|
Merge Healthcare Announces Adjournment of
Annual Shareholder's Meeting
Milwaukee , WI , December 18, 2006 - Merge Technologies Incorporated, d.b.a. Merge Healthcare (NASDAQ: MRGE; TSX: MRG), announced that it adjourned its annual shareholder's meeting that was convened today because the quorum required by the Company's by-laws (a majority of the shares of stock outstanding) was not obtained. The annual meeting will be reconvened on Thursday, December 28, 2006 at 12:00 PM (Central Time). The additional time will allow Merge Healthcare shareholders to cast their votes relative to the proposed reelection of eleven individuals to serve as Directors of the Company until its 2007 Annual Meeting of Shareholders. The brief, reconvened meeting will be held at the Company’s corporate headquarters at 6737 West Washington Street, Suite 2250, Milwaukee, WI, 53214.
Following adjournment of the formal portion of the meeting today, Ken Rardin, the Company’s President and Chief Executive Officer, discussed an overview of his first 100 days with Merge Healthcare, including customer ROI for its solutions and market potential for Merge Healthcare products and services. The following provides a link to today’s presentation:
http://www.mergehealthcare.com/investorrelations/presentations.htm
At the time of the adjournment, a preliminary count indicated that approximately 40% of the outstanding shares were represented either in person or by proxy.
Any shareholder of record as of the close of business on November 10, 2006, who did not receive the Company's proxy materials should contact Julie Ann Schumitsch at (414) 977-4000 or shareholderinfo@merge.com, to receive such materials and vote their shares. Any shareholder who held shares in "street name" through their broker, bank or other custodian as of the close of business on November 10, 2006, should contact such custodian to receive proxy materials and vote their shares.
"We appreciate those shareholders who have submitted proxies in support of the reelection of the Company’s Board of Directors and urge all Merge Healthcare shareholders to vote their shares," said Mr. Rardin.
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
